REPAIR: long-term effects of macitentan on the right ventricle (RV) in pulmonary arterial hypertension (PAH)
D. Kiely (Sheffield (South Yorkshire), United Kingdom), E. Cottreel (Allschwil, Switzerland), N. Galiè (Bologna, Italy), J. Marcus (Amsterdam, Netherlands), A. Peacock (Glasgow, United Kingdom), S. Rosenkranz (Cologne, Germany), A. Swift (Sheffield, United Kingdom), A. Tawakol (Boston, United States of America), A. Torbicki (Otwock, Poland), A. Vonk Noordegraaf (Amsterdam, Netherlands), G. Wetherill (Allschwil, Switzerland), R. Channick (Los Angeles, United States of America)
Source: Virtual Congress 2020 – Updated assessment and treatment of pulmonary arterial hypertension
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Kiely (Sheffield (South Yorkshire), United Kingdom), E. Cottreel (Allschwil, Switzerland), N. Galiè (Bologna, Italy), J. Marcus (Amsterdam, Netherlands), A. Peacock (Glasgow, United Kingdom), S. Rosenkranz (Cologne, Germany), A. Swift (Sheffield, United Kingdom), A. Tawakol (Boston, United States of America), A. Torbicki (Otwock, Poland), A. Vonk Noordegraaf (Amsterdam, Netherlands), G. Wetherill (Allschwil, Switzerland), R. Channick (Los Angeles, United States of America). REPAIR: long-term effects of macitentan on the right ventricle (RV) in pulmonary arterial hypertension (PAH). 3971
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: